You are here

Clinical Trials: Wounds and Injuries

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, January 23, 2023 - 12:00
Condition:   Congenital Pseudarthrosis of Tibia
Intervention:   Biological: NVD-003, an autologous 3D scaffold free osteogenic graft
Sponsor:   Novadip Biosciences
Posted: Friday, January 20, 2023 - 12:00
Condition:   Spinal Cord Injury, Acute
Interventions:   Biological: Multiple systemic (i.v.) administration of allogenic non-related group- and rhesus-compatible mononuclear cord blood cells;   Other: Control vehicle (sterile saline)
Sponsors:   Sklifosovsky Institute of Emergency Care;   State-Financed Health Facility "Samara Regional Medical Center Dinasty";   K.L. Hetagurov North-Osetian State University
Posted: Tuesday, January 10, 2023 - 12:00
Condition:   Complex Perianal Fistulas
Interventions:   Biological: Human TH-SC01 Cell Injection;   Other: Saline solution
Sponsors:   Jiangsu Topcel-KH Pharmaceutical Co., Ltd.;   Xiangya Hospital of Central South University
Not yet recruiting
Posted: Friday, December 30, 2022 - 12:00
Condition:   Long COVID
Interventions:   Procedure: Adipose Tissue Harvest;   Biological: ATCell
Sponsor:   American CryoStem Corporation
Not yet recruiting
Posted: Thursday, December 15, 2022 - 12:00
Conditions:   Burn Degree Second;   Burn Degree Third
Interventions:   Procedure: Split-thickness skin graft;   Biological: Artificial skin graft;   Biological: Artificial skin graft co-culture
Sponsor:   Indonesia University
Posted: Thursday, September 22, 2022 - 12:00
Condition:   Venous Leg Ulcer
Interventions:   Biological: XSTEM-VLU;   Other: Vehicle
Sponsors:   Xintela AB;   Vinnova
Not yet recruiting
Posted: Friday, May 13, 2022 - 12:00
Condition:   Diabetic Foot
Interventions:   Biological: SkinTE;   Other: Control
Sponsors:   PolarityTE;   Alira Health
Posted: Thursday, March 24, 2022 - 12:00
Condition:   Sequelae of Injuries of Head
Interventions:   Biological: autologous bone marrow-derived mononuclear cell transplantation;   Other: Rehabilitation therapy
Sponsor:   Vinmec Research Institute of Stem Cell and Gene Technology
Posted: Wednesday, December 15, 2021 - 12:00
Condition:   Dystrophic Epidermolysis Bullosa
Interventions:   Biological: ALLO-ASC-SHEET;   Other: Vehicle Control
Sponsor:   Anterogen Co., Ltd.
Not yet recruiting
Posted: Wednesday, December 15, 2021 - 12:00
Conditions:   Testicular Injury;   Oligospermia
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine